KCT0008689招募中Unknown
A 8 weeks, multi-center, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Agrimonia pilosa extract powder on improvement of Liver function
Wonkwang University, Gwangju Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •1) Adult men and women aged 19 years or older and 75 years or less at the screening test
- •2) Participants whose blood ALT level within 46~135 U/L
- •3) A person who, after hearing and fully understanding the detailed explanation of this trial, voluntarily decides to participate and agrees in writing to comply with the precautions
排除标准
- •1) Acute or chronic hepatitis patients or individuals with Hepatitis B or Hepatitis C virus infection
- •2) Individuals with liver cirrhosis, liver cancer, or signs suggestive of liver cancer.
- •3) Individuals with a BMI of less than 18.5 kg/m^2 or greater than 35 kg/m^2 at screening
- •4) Those who have taken liver function improving drugs and health functional foods within 1 month prior to screening
- •5) Those with a history of clinically significant hypersensitivity to Agrimonia pilosa
- •6) Pregnant or lactating women
- •7) Women of childbearing potential who do not accept the practice of adequate contraception
- •8) Those who participated in other clinical trials within 3 months prior to screening
- •9) A person who is judged unsuitable for participation in the study by the director of the study due to diagnostic test results and other reasons
研究者
相似试验
招募中
不适用
A human trial to evaluate the efficacy and safety of enzyme-treated Zizania latifolia (Griseb.) Turcz. ex Stapf extract powder on improvement of Liver functioKCT0005510Wonkwang University Oriental Medical Hospital, Jeonju100
招募中
不适用
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Magnolia extract on gingival healthKCT0006746O100
已完成
不适用
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of MAEC on gingival healthCongenital malformations, deformations and chromosomal abnormalitiesKCT0005569MedibioLAB100
进行中（未招募）
不适用
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertensioHypertensionEUCTR2006-000774-70-GBovartis Pharma Services AG2,252
进行中（未招募）
不适用
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertensioHypertensionEUCTR2006-000774-70-SEovartis Pharma Services AG2,252